Temple Law to Honor Sheller with Doctor of Humane Letters

1
Shares

Unknown

Attorney Stephen Sheller, founder of Sheller PC, will be honored with a doctor of humane letters degree at Temple University’s Beasley School of Law 2019 Commencement Ceremony on May 16.

The Beasley School of Law will celebrate Stephen A. Sheller, founding and managing partner of Sheller, P.C. and a passionate advocate for underdog clients. His philanthropic support helped establish the Stephen and Sandra Sheller Center for Social Justice at Beasley.

The Stephen and Sandra Center for Social Justice, established in 2013, is a hub for social justice and advocacy seeking justice for the disadvantaged populations in Philadelphia and across Pennsylvania. The Center is just one many philanthropic community and civic responsibility programs in which the Sheller Family Foundation is involved.

Sheller is known for his work advocating for those injured by pharmaceutical drugs and his involvement in numerous whistleblower cases. He tells his story of taking on the pharmacutical industry in his new book “Big Pharma, Big Greed.” Read excerpts from the book here.

Sheller filed litigation in the infamous Bush v. Gore presidential election’s “butterfly ballot” scandal in Palm Beach County, Florida.

“Temple bestows honorary degrees upon leaders from many backgrounds and fields whose achievements exemplify the university’s ideals and mission. The university has awarded nearly 900 honorary degrees throughout its history.

“’We are proud to welcome such distinguished leaders in their field,’ said Temple University President Richard M. Englert in a statement. ‘Their contributions to Temple, North Philadelphia and beyond make these individuals ideal choices to receive honorary degrees. They will undoubtedly serve as inspirations to our many terrific graduates, who are bound for similarly remarkable futures.’”

Bernard Hopkins and Fran Dunphy to receive honorary degrees, The Philadelphia Tribune, May 2, 2019

Previous post

April 23rd, Book Signing: Big Pharma Big Greed

Next post

This is the latest news article.